Publications:

---

Longitudinal Analyses of Mutational Subclonal Architecture and Tumor Subtypes in Recurrent Bladder Cancer.

International Journal Of Molecular Sciences

Ryu, Daeun D; Kim, Tae-Min TM; Lee, Yun-Hee YH; Ha, U-Syn US

Publication Date: 2023-05-08

Variant appearance in text: ERBB2: S310Y

PubMed Link: 37176124

Variant Present in the following documents:

• Main text
• ijms-24-08418.pdf

View BVdb publication page

---

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Nature Communications

Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA

Publication Date: 2023-04-03

Variant appearance in text: ERBB2: S310Y

PubMed Link: 37012232

Variant Present in the following documents:

• 41467_2023_37547_MOESM10_ESM.xlsx, sheet 4
• 41467_2023_37547_MOESM10_ESM.xlsx, sheet 3
• 41467_2023_37547_MOESM10_ESM.xlsx, sheet 2
• 41467_2023_37547_MOESM12_ESM.xlsx, sheet 3
• 41467_2023_37547_MOESM12_ESM.xlsx, sheet 2

View BVdb publication page

---

Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes.

Nature Communications

Li, Lingling L; Jiang, Dongxian D; Liu, Hui H; Guo, Chunmei C; Zhao, Rui R; Zhang, Qiao Q; Xu, Chen C; Qin, Zhaoyu Z; Feng, Jinwen J; Liu, Yang Y; Wang, Haixing H; Chen, Weijie W; Zhang, Xue X; Li, Bin B; Bai, Lin L; Tian, Sha S; Tan, Subei S; Yu, Zixiang Z; Chen, Lingli L; Huang, Jie J; Zhao, Jian-Yuan JY; Hou, Yingyong Y; Ding, Chen C

Publication Date: 2023-03-29

Variant appearance in text: rs1057519816

PubMed Link: 36991000

Variant Present in the following documents:

• 41467_2023_37221_MOESM5_ESM.xlsx, sheet 3

View BVdb publication page

---

Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

Nature Communications

Harding, James J JJ; Piha-Paul, Sarina A SA; Shah, Ronak H RH; Murphy, Jessica J JJ; Cleary, James M JM; Shapiro, Geoffrey I GI; Quinn, David I DI; Braña, Irene I; Moreno, Victor V; Borad, Mitesh M; Loi, Sherene S; Spanggaard, Iben I; Park, Haeseong H; Ford, James M JM; Arnedos, Mónica M; Stemmer, Salomon M SM; de la Fouchardiere, Christelle C; Fountzilas, Christos C; Zhang, Jie J; DiPrimeo, Daniel D; Savin, Casey C; Duygu Selcuklu, S S; Berger, Michael F MF; Eli, Lisa D LD; Meric-Bernstam, Funda F; Jhaveri, Komal K; Solit, David B DB; Abou-Alfa, Ghassan K GK

Publication Date: 2023-02-06

Variant appearance in text: ERBB2: S310Y

PubMed Link: 36746967

Variant Present in the following documents:

• 41467_2023_36399_MOESM1_ESM.pdf
• 41467_2023_Article_36399.pdf
• 41467_2023_36399_MOESM3_ESM.xlsx, sheet 5

View BVdb publication page

---

Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes-A Case Report with Literature Review.

International Journal Of Molecular Sciences

Grenda, Anna A; Krawczyk, Pawel P; Targowska-Duda, Katarzyna M KM; Kieszko, Robert R; Paśnik, Iwona I; Milanowski, Janusz J

Publication Date: 2023-01-07

Variant appearance in text: ERBB2: S310Y

PubMed Link: 36674722

Variant Present in the following documents:

• Main text
• ijms-24-01195.pdf

View BVdb publication page

---

Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)

Eli, Lisa D LD; Kavuri, Shyam M SM

Publication Date: 2022

Variant appearance in text: HER2: S310Y

PubMed Link: 36627899

Variant Present in the following documents:

• cdr-5-4-873.pdf

View BVdb publication page

---

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology

Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y

Publication Date: 2022

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 36505399

Variant Present in the following documents:

• Table_2.xlsx, sheet 3
• Table_2.xlsx, sheet 2

View BVdb publication page

---

Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors.

Elife

Kang, Minsu M; Na, Hee Young HY; Ahn, Soomin S; Kim, Ji-Won JW; Lee, Sejoon S; Ahn, Soyeon S; Lee, Ju Hyun JH; Youk, Jeonghwan J; Kim, Haesook T HT; Kim, Kui-Jin KJ; Suh, Koung Jin KJ; Lee, Jun Suh JS; Kim, Se Hyun SH; Kim, Jin Won JW; Kim, Yu Jung YJ; Lee, Keun-Wook KW; Yoon, Yoo-Seok YS; Kim, Jee Hyun JH; Chung, Jin-Haeng JH; Han, Ho-Seong HS; Lee, Jong Seok JS

Publication Date: 2022-12-08

Variant appearance in text: ERBB2: S310Y

PubMed Link: 36476508

Variant Present in the following documents:

• elife-78636-supp2.xlsx, sheet 7

View BVdb publication page

---

Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.

Nature Communications

Sivakumar, Smruthy S; Jin, Dexter X DX; Tukachinsky, Hanna H; Murugesan, Karthikeyan K; McGregor, Kimberly K; Danziger, Natalie N; Pavlick, Dean D; Gjoerup, Ole O; Ross, Jeffrey S JS; Harmon, Robert R; Chung, Jon J; Decker, Brennan B; Dennis, Lucas L; Frampton, Garrett M GM; Molinero, Luciana L; Oesterreich, Steffi S; Venstrom, Jeffrey M JM; Oxnard, Geoffrey R GR; Hegde, Priti S PS; Sokol, Ethan S ES

Publication Date: 2022-12-05

Variant appearance in text: ERBB2: S310Y

PubMed Link: 36470901

Variant Present in the following documents:

• 41467_2022_35245_MOESM4_ESM.xlsx, sheet 17

View BVdb publication page

---

Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer.

Thoracic Cancer

Zhang, Shirong S; Wang, Wenxian W; Xu, Chunwei C; Zhang, Yongchang Y; Cai, Xiuyu X; Wang, Qian Q; Song, Zhengbo Z; Li, Ziming Z; Yu, Jinpu J; Zhong, Wenzhao W; Wang, Zhijie Z; Liu, Jingjing J; Liu, Anwen A; Li, Wen W; Zhan, Ping P; Liu, Hongbing H; Lv, Tangfeng T; Miao, Liyun L; Min, Lingfeng L; Lin, Gen G; Huang, Long L; Yuan, Jingping J; Jiang, Zhansheng Z; Pu, Xingxiang X; Rao, Chuangzhou C; Lv, Dongqing D; Yu, Zongyang Z; Li, Xiaoyan X; Tang, Chuanhao C; Zhou, Chengzhi C; Zhang, Junping J; Guo, Hui H; Chu, Qian Q; Meng, Rui R; Liu, Xuewen X; Wu, Jingxun J; Zhou, Jin J; Zhu, Zhengfei Z; Pan, Weiwei W; Dong, Xiaowei X; Pang, Fei F; Wang, Kai K; Yao, Chao C; Lin, Guomin G; Li, Site S; Yang, Zhi Z; Luo, Jiancheng J; Jia, Hongtao H; Nie, Xiuqing X; Wang, Liping L; Zhu, Youcai Y; Hu, Xiao X; Xie, Yanru Y; Lin, Xinqing X; Cai, Jing J; Xia, Yang Y; Feng, Huijing H; Wang, Lin L; Du, Yingying Y; Yao, Wang W; Shi, Xuefei X; Niu, Xiaomin X; Yuan, Dongmei D; Yao, Yanwen Y; Kang, Jing J; Zhang, Jiatao J; Zhang, Chao C; Gao, Wenbin W; Huang, Jianhui J; Zhang, Yinbin Y; Sun, Pingli P; Wang, Hong H; Ye, Mingxiang M; Wang, Dong D; Wang, Zhaofeng Z; Wan, Bing B; Lv, Donglai D; Yu, Genhua G; Shi, Lin L; Xia, Yuanli Y; Gao, Feng F; Zhang, Xiaochen X; Xu, Tao T; Zhou, Wei W; Wang, Haixia H; Liu, Zhefeng Z; Yang, Nong N; Wu, Lin L; Wang, Qiming Q; Wang, Guansong G; Hong, Zhuan Z; Wang, Jiandong J; Fang, Meiyu M; Fang, Yong Y; Zhang, Yiping Y; Song, Yong Y; Ma, Shenglin S; Fang, Wenfeng W; Lu, Yuanzhi Y

Publication Date: 2022-11-28

Variant appearance in text: HER2: S310Y

PubMed Link: 36444143

Variant Present in the following documents:

• Main text
• TCA-14-91.pdf

View BVdb publication page

---

Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing.

Cancer Research And Treatment

Ahn, Beung-Chul BC; Han, Ye-Jeong YJ; Kim, Hye Ryun HR; Hong, Min Hee MH; Cho, Byoung Chul BC; Lim, Sun Min SM

Publication Date: 2022-11-09

Variant appearance in text: HER2: S310Y

PubMed Link: 36397236

Variant Present in the following documents:

• crt-2022-359.pdf

View BVdb publication page

---

Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications

Boström, Martin M; Larsson, Erik E

Publication Date: 2022-11-17

Variant appearance in text: ERBB2: S310Y

PubMed Link: 36396655

Variant Present in the following documents:

• 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page

---

Immunotherapy for bilateral multiple ground glass opacities: An exploratory study for synchronous multiple primary lung cancer.

Frontiers In Immunology

Xu, Lin L; Shi, Meiqi M; Wang, Siwei S; Li, Ming M; Yin, Wenda W; Zhang, Jingyuan J; Zhu, Jun J; Jiang, Feng F; Xia, Wenjia W; Qiu, Ninglei N; Zhang, Zhi Z; Huang, Jianfeng J; Ma, Zhifei Z; Meng, Fanchen F; Zhu, Hongyu H; Dong, Guozhang G; Wang, Jie J; Yin, Rong R

Publication Date: 2022

Variant appearance in text: rs1057519816

PubMed Link: 36389707

Variant Present in the following documents:

• DataSheet_1.xlsx, sheet 2

View BVdb publication page

---

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.

Bmc Medical Genomics

Liu, Jing J; Li, Zirong Z; Lu, Ting T; Pan, Junping J; Li, Li L; Song, Yanwen Y; Hu, Dan D; Zhuo, Yanhong Y; Chen, Ying Y; Xu, Qin Q

Publication Date: 2022-11-04

Variant appearance in text: ERBB2: 929C>A; Ser310Tyr

PubMed Link: 36333792

Variant Present in the following documents:

• 12920_2022_1376_MOESM1_ESM.xlsx, sheet 1

View BVdb publication page

---

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.

International Journal Of Molecular Sciences

Albarrán, Víctor V; Rosero, Diana Isabel DI; Chamorro, Jesús J; Pozas, Javier J; San Román, María M; Barrill, Ana María AM; Alía, Víctor V; Sotoca, Pilar P; Guerrero, Patricia P; Calvo, Juan Carlos JC; Orejana, Inmaculada I; Pérez de Aguado, Patricia P; Gajate, Pablo P

Publication Date: 2022-10-21

Variant appearance in text: ERBB2: S310Y

PubMed Link: 36293515

Variant Present in the following documents:

• Main text
• ijms-23-12659.pdf

View BVdb publication page

---

Urethral Melanoma - Clinical, Pathological and Molecular Characteristics.

Bladder Cancer (Amsterdam, Netherlands)

Mano, Roy R; Hoeh, Benedikt B; DiNatale, Renzo G RG; Sanchez, Alejandro A; Benfante, Nicole E NE; Reznik, Ed E; Leitao, Mario M MM; Shoushtari, Alexander N AN; Goh, Alvin A; Donat, S Machele SM; Herr, Harry W HW; Bochner, Bernard H BH; Dalbagni, Guido G; Donahue, Timothy F TF

Publication Date: 2022

Variant appearance in text: ERBB2: S310Y

PubMed Link: 36277327

Variant Present in the following documents:

• Main text
• blc-8-blc211633.pdf

View BVdb publication page

---

Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma.

The Journal Of Pathology

Birkeälv, Sofia S; Harland, Mark M; Matsuyama, Larissa Satiko Alcantara Sekimoto LSAS; Rashid, Mamun M; Mehta, Ishan I; Laye, Jonathan P JP; Haase, Kerstin K; Mell, Tracey T; Iyer, Vivek V; Robles-Espinoza, Carla Daniela CD; McDermott, Ultan U; van Loo, Peter P; Kuijjer, Marieke L ML; Possik, Patricia A PA; Maria Engler, Silvya Stuchi SS; Bishop, D Timothy DT; Newton-Bishop, Julia J; Adams, David J DJ

Publication Date: 2022-10-11

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 36219477

Variant Present in the following documents:

• PATH-259-56-s004.xlsx, sheet 2

View BVdb publication page

---

Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers.

Bmc Cancer

Wu, Huita H; Ji, Haonan H; Yang, Wenhui W; Zhang, Min M; Guo, Yifang Y; Li, Bangkai B; Wang, Jiayin J; Chen, Rongrong R; Chen, Yuan Y; Wang, Xin X

Publication Date: 2022-09-27

Variant appearance in text: ERBB2: S310Y

PubMed Link: 36167530

Variant Present in the following documents:

• 12885_2022_9922_MOESM5_ESM.xlsx, sheet 1

View BVdb publication page

---

S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer.

Molecular Cancer

Mo, Hongnan H; Liu, Xuefeng X; Xue, Yu Y; Chen, Hongyan H; Guo, Shichao S; Li, Zhangfu Z; Wang, Shuang S; Li, Caiming C; Han, Jiashu J; Fu, Ming M; Song, Yongmei Y; Li, Dan D; Ma, Fei F

Publication Date: 2022-08-30

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 36042494

Variant Present in the following documents:

• 12943_2022_1642_MOESM4_ESM.xlsx, sheet 1

View BVdb publication page

---

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.

Molecular Oncology

Zhang, Lanxin L; Sun, Siwen S; Zhao, Xiaotian X; Liu, Jingwen J; Xu, Yang Y; Xu, Lingzhi L; Song, Chen C; Li, Na N; Yu, Jing J; Zhao, Shanshan S; Yu, Peiyao P; Fang, Fengqi F; Xie, Jiping J; Ji, Xuening X; Yu, Ruoying R; Ou, Qiuxiang Q; Zhao, Zuowei Z; Li, Man M

Publication Date: 2022-10

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 35971249

Variant Present in the following documents:

• MOL2-16-3689-s005.xlsx, sheet 1

View BVdb publication page

---

Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma.

Frontiers In Oncology

Yin, Xiang-Qian XQ; Yin, Xue-Hui XH; Yu, Ya-Qin YQ; Xu, Lang L; Zhang, Mao M

Publication Date: 2022

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 35936718

Variant Present in the following documents:

• Table_4.xlsx, sheet 2

View BVdb publication page

---

Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors.

Pathology Oncology Research : Por

Wang, Hao H; Miao, Ji J; Wen, Yazhou Y; Xia, Xihua X; Chen, Yanan Y; Huang, Mengli M; Chen, Shiqing S; Zhao, Zhengyi Z; Zhang, Yuzi Y; Chen, Chunzhu C; Zhu, Xinhua X

Publication Date: 2022

Variant appearance in text: ERBB2: S310Y

PubMed Link: 35911441

Variant Present in the following documents:

• Main text
• pore-28-1610360.pdf

View BVdb publication page

---

Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer.

Cancer Research

Kalra, Rashi R; Chen, Ching Hui CH; Wang, Junkai J; Salam, Ahmad Bin AB; Dobrolecki, Lacey E LE; Lewis, Alaina A; Sallas, Christina C; Yates, Clayton C CC; Gutierrez, Carolina C; Karanam, Balasubramanyam B; Anurag, Meenakshi M; Lim, Bora B; Ellis, Matthew J MJ; Kavuri, Shyam M SM

Publication Date: 2022-08-16

Variant appearance in text: HER2: S310Y

PubMed Link: 35736563

Variant Present in the following documents:

• can-21-3106_supplementary_data_suppst1.xlsx, sheet 2

View BVdb publication page

---

Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes.

Genome Medicine

Goel, Anshita A; Ward, Douglas G DG; Noyvert, Boris B; Yu, Minghao M; Gordon, Naheema S NS; Abbotts, Ben B; Colbourne, John K JK; Kissane, Stephen S; James, Nicholas D ND; Zeegers, Maurice P MP; Cheng, Kar Keung KK; Cazier, Jean-Baptiste JB; Whalley, Celina M CM; Beggs, Andrew D AD; Palles, Claire C; Arnold, Roland R; Bryan, Richard T RT

Publication Date: 2022-06-03

Variant appearance in text: ERBB2: 929C>A; Ser310Tyr

PubMed Link: 35655252

Variant Present in the following documents:

• 13073_2022_1056_MOESM1_ESM.xlsx, sheet 3

View BVdb publication page

---

Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging

Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M

Publication Date: 2022-05-25

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 35613927

Variant Present in the following documents:

• aging-14-204101-s004.xlsx, sheet 1

View BVdb publication page

---

Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects.

Cancer Research

Ishiyama, Noboru N; O'Connor, Matthew M; Salomatov, Andrei A; Romashko, Darlene D; Thakur, Shalabh S; Mentes, Ahmet A; Hopkins, Julia F JF; Frampton, Garrett M GM; Albacker, Lee A LA; Kohlmann, Anna A; Roberts, Christopher C; Buck, Elizabeth E

Publication Date: 2022-05-03

Variant appearance in text: HER2: S310Y

PubMed Link: 35503682

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Acquired Concurrent EGFR T790M and Driver Gene Resistance From EGFR-TKIs Hampered Osimertinib Efficacy in Advanced Lung Adenocarcinoma: Case Reports.

Frontiers In Pharmacology

Zeng, Yue Y; Feng, Yuanqing Y; Fu, Guihua G; Jiang, Junlan J; Liu, Xiaohan X; Pan, Yue Y; Hu, Chunhong C; Liu, Xianling X; Wu, Fang F

Publication Date: 2022

Variant appearance in text: HER2: S310Y

PubMed Link: 35462930

Variant Present in the following documents:

• Main text
• fphar-13-838247.pdf

View BVdb publication page

---

Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case Series.

Healthcare (Basel, Switzerland)

Guerrera, Luigi Pio LP; Suarato, Gabriella G; Napolitano, Rossella R; Perrone, Alessandra A; Caputo, Vincenza V; Ventriglia, Anna A; Martini, Giulia G; Della Corte, Carminia Maria CM; Orditura, Michele M; Martinelli, Erika E; Ciardiello, Fortunato F; Montella, Marco M; Franco, Renato R; Troiani, Teresa T; Napolitano, Stefania S

Publication Date: 2022-04-11

Variant appearance in text: ERBB2: S310Y

PubMed Link: 35455885

Variant Present in the following documents:

• Main text
• healthcare-10-00708.pdf

View BVdb publication page

---

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Cancer Medicine

Liu, Binliang B; Yi, Zongbi Z; Guan, Yanfang Y; Ouyang, Quchang Q; Li, Chunxiao C; Guan, Xiuwen X; Lv, Dan D; Li, Lixi L; Zhai, Jingtong J; Qian, Haili H; Xu, Binghe B; Ma, Fei F; Zeng, Yixin Y

Publication Date: 2022-07

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 35393784

Variant Present in the following documents:

• CAM4-11-2767-s001.xlsx, sheet 1

View BVdb publication page

---

Clinical and genomic features of Chinese lung cancer patients with germline mutations.

Nature Communications

Peng, Wenying W; Li, Bin B; Li, Jin J; Chang, Lianpeng L; Bai, Jing J; Yi, Yuting Y; Chen, Rongrong R; Zhang, Yanyan Y; Chen, Chen C; Pu, Xingxiang X; Jiang, Meilin M; Li, Jia J; Zhong, Rui R; Xu, Fang F; Chen, Bolin B; Xu, Li L; Wang, Ning N; Huan, Jiaojiao J; Dai, Pingping P; Guan, Yanfang Y; Yang, Ling L; Xia, Xuefeng X; Yi, Xin X; Wang, Jiayin J; Yu, Fenglei F; Wu, Lin L

Publication Date: 2022-03-10

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 35273153

Variant Present in the following documents:

• 41467_2022_28840_MOESM7_ESM.xlsx, sheet 1

View BVdb publication page

---

Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022.

Cancers

Hu, Zishuo Ian ZI; Lim, Kian-Huat KH

Publication Date: 2022-02-28

Variant appearance in text: HER2: S310Y

PubMed Link: 35267556

Variant Present in the following documents:

• Main text
• cancers-14-01249.pdf

View BVdb publication page

---

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer

Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J

Publication Date: 2022-02

Variant appearance in text: ERBB2: Ser310Tyr

PubMed Link: 35221333

Variant Present in the following documents:

• 43018_2022_332_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

Identifying Actionable Variants Using Capture-Based Targeted Sequencing in 563 Patients With Non-Small Cell Lung Carcinoma.

Frontiers In Oncology

Jiang, Haiping H; Wang, Yinan Y; Xu, Hanlin H; Lei, Wei W; Yu, Xiaoyun X; Tian, Haiying H; Meng, Cong C; Wang, Xueying X; Zhao, Zicheng Z; Jin, Xiangfeng X

Publication Date: 2021

Variant appearance in text: ERBB2: S310Y; rs1057519816

PubMed Link: 35186718

Variant Present in the following documents:

• Table_1.xlsx, sheet 2

View BVdb publication page

---

Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer.

Balkan Medical Journal

Kahraman Çetin, Nesibe N; Erdoğdu, İbrahim Halil İH; Bozkurt, Emin E; Meteoğlu, İbrahim İ

Publication Date: 2021-11

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 34860166

Variant Present in the following documents:

• bmj-38-6-382.pdf

View BVdb publication page

---

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology

Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C

Publication Date: 2021

Variant appearance in text: ERBB2: S310Y

PubMed Link: 34630336

Variant Present in the following documents:

• Table_1.xlsx, sheet 2

View BVdb publication page

---

A Metastatic Cervical Adenocarcinoma Patient Carrying HER2 G292R Achieved Complete Response Upon Pyrotinib Treatment.

Oncotargets And Therapy

Liu, Jing J; Zhuo, Yanhong Y; Wang, Feng F; Li, Zirong Z; Lin, Yibin Y; Li, Li L; Pan, Junping J; Song, Yanwen Y; Du, Haiwei H; Li, Chanhe C; Xu, Qin Q

Publication Date: 2021

Variant appearance in text: HER2: S310Y

PubMed Link: 34556997

Variant Present in the following documents:

• Main text
• ott-14-4833.pdf

View BVdb publication page

---

Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer.

Nature Communications

Lin, Jianzhen J; Peng, Xinxin X; Dong, Kun K; Long, Junyu J; Guo, Xuejiao X; Li, Hongyue H; Bai, Yi Y; Yang, Xu X; Wang, Dongxu D; Lu, Xin X; Mao, Yilei Y; Sang, Xinting X; Ji, Xuwo X; Zhao, Haitao H; Liang, Han H

Publication Date: 2021-08-06

Variant appearance in text: ERBB2: S310Y

PubMed Link: 34362903

Variant Present in the following documents:

• 41467_2021_25012_MOESM3_ESM.xlsx, sheet 2

View BVdb publication page

---

Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA.

Npj Precision Oncology

Finkle, Justin D JD; Boulos, Hala H; Driessen, Terri M TM; Lo, Christine C; Blidner, Richard A RA; Hafez, Ashraf A; Khan, Aly A AA; Lozac'hmeur, Ariane A; McKinnon, Kelly E KE; Perera, Jason J; Zhu, Wei W; Dowlati, Afshin A; White, Kevin P KP; Tell, Robert R; Beaubier, Nike N

Publication Date: 2021-07-02

Variant appearance in text: ERBB2: Ser310Tyr

PubMed Link: 34215841

Variant Present in the following documents:

• 41698_2021_202_MOESM1_ESM.pdf

View BVdb publication page

---

Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.

Breast Cancer Research And Treatment

Nteliopoulos, Georgios G; Page, Karen K; Hills, Allison A; Howarth, Karen K; Emmett, Warren W; Green, Emma E; Martinson, Luke J LJ; Fernadez-Garcia, Daniel D; Hastings, Robert R; Guttery, David S DS; Kenny, Laura L; Stebbing, Justin J; Cleator, Susan S; Rehman, Farah F; Gleason, Kelly L T KLT; Sanela, Andrijac A; Ion, Charlotte C; Rushton, Amelia J AJ; Rosenfeld, Nitzan N; Coombes, R Charles RC; Shaw, Jacqueline A JA

Publication Date: 2021-07

Variant appearance in text: ERBB2: S310Y

PubMed Link: 34097174

Variant Present in the following documents:

• 10549_2021_6220_MOESM2_ESM.xlsx, sheet 4
• 10549_2021_6220_MOESM1_ESM.pdf

View BVdb publication page

---

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.

Genome Medicine

Tsui, Dana W Y DWY; Cheng, Michael L ML; Shady, Maha M; Yang, Julie L JL; Stephens, Dennis D; Won, Helen H; Srinivasan, Preethi P; Huberman, Kety K; Meng, Fanli F; Jing, Xiaohong X; Patel, Juber J; Hasan, Maysun M; Johnson, Ian I; Gedvilaite, Erika E; Houck-Loomis, Brian B; Socci, Nicholas D ND; Selcuklu, S Duygu SD; Seshan, Venkatraman E VE; Zhang, Hongxin H; Chakravarty, Debyani D; Zehir, Ahmet A; Benayed, Ryma R; Arcila, Maria M; Ladanyi, Marc M; Funt, Samuel A SA; Feldman, Darren R DR; Li, Bob T BT; Razavi, Pedram P; Rosenberg, Jonathan J; Bajorin, Dean D; Iyer, Gopa G; Abida, Wassim W; Scher, Howard I HI; Rathkopf, Dana D; Viale, Agnes A; Berger, Michael F MF; Solit, David B DB

Publication Date: 2021-05-31

Variant appearance in text: ERBB2: S310Y

PubMed Link: 34059130

Variant Present in the following documents:

• 13073_2021_898_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting.

Diagnostics (Basel, Switzerland)

Sultova, Elena E; Westphalen, C Benedikt CB; Jung, Andreas A; Kumbrink, Joerg J; Kirchner, Thomas T; Mayr, Doris D; Rudelius, Martina M; Ormanns, Steffen S; Heinemann, Volker V; Metzeler, Klaus H KH; Greif, Philipp A PA; Hester, Anna A; Mahner, Sven S; Harbeck, Nadia N; Wuerstlein, Rachel R

Publication Date: 2021-04-20

Variant appearance in text: ERBB2: 929C>A

PubMed Link: 33924134

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Comprehensive omic characterization of breast cancer in Mexican-Hispanic women.

Nature Communications

Romero-Cordoba, Sandra L SL; Salido-Guadarrama, Ivan I; Rebollar-Vega, Rosa R; Bautista-Piña, Veronica V; Dominguez-Reyes, Carlos C; Tenorio-Torres, Alberto A; Villegas-Carlos, Felipe F; Fernández-López, Juan C JC; Uribe-Figueroa, Laura L; Alfaro-Ruiz, Luis L; Hidalgo-Miranda, Alfredo A

Publication Date: 2021-04-14

Variant appearance in text: ERBB2: S310Y

PubMed Link: 33854067

Variant Present in the following documents:

• 41467_2021_22478_MOESM8_ESM.xlsx, sheet 9

View BVdb publication page

---

Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients.

Scientific Reports

Muendlein, Axel A; Geiger, Kathrin K; Gaenger, Stella S; Dechow, Tobias T; Nonnenbroich, Christoph C; Leiherer, Andreas A; Drexel, Heinz H; Gaumann, Andreas A; Jagla, Wolfgang W; Winder, Thomas T; Mayer, Frank F; Decker, Thomas T

Publication Date: 2021-03-24

Variant appearance in text: ERBB2: 929C>A; Ser310Tyr

PubMed Link: 33762647

Variant Present in the following documents:

• 41598_2021_86238_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review.

Oncotargets And Therapy

Qu, Yanchun Y; Liu, Yufeng Y; Ding, Kailin K; Li, Yong Y; Hong, Xiaoyu X; Zhang, Haibo H

Publication Date: 2021

Variant appearance in text: HER2: S310Y

PubMed Link: 33688205

Variant Present in the following documents:

• Main text
• ott-14-1581.pdf

View BVdb publication page

---

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.

Bmc Cancer

Huang, Chi-Cheng CC; Tsai, Yi-Fang YF; Liu, Chun-Yu CY; Chao, Ta-Chung TC; Lien, Pei-Ju PJ; Lin, Yen-Shu YS; Feng, Chin-Jung CJ; Chiu, Jen-Hwey JH; Hsu, Chih-Yi CY; Tseng, Ling-Ming LM

Publication Date: 2021-02-25

Variant appearance in text: ERBB2: S310Y

PubMed Link: 33632156

Variant Present in the following documents:

• Main text
• 12885_2021_Article_7931.pdf

View BVdb publication page

---

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.

Jama Oncology

Cobain, Erin F EF; Wu, Yi-Mi YM; Vats, Pankaj P; Chugh, Rashmi R; Worden, Francis F; Smith, David C DC; Schuetze, Scott M SM; Zalupski, Mark M MM; Sahai, Vaibhav V; Alva, Ajjai A; Schott, Anne F AF; Caram, Megan E V MEV; Hayes, Daniel F DF; Stoffel, Elena M EM; Jacobs, Michelle F MF; Kumar-Sinha, Chandan C; Cao, Xuhong X; Wang, Rui R; Lucas, David D; Ning, Yu Y; Rabban, Erica E; Bell, Janice J; Camelo-Piragua, Sandra S; Udager, Aaron M AM; Cieslik, Marcin M; Lonigro, Robert J RJ; Kunju, Lakshmi P LP; Robinson, Dan R DR; Talpaz, Moshe M; Chinnaiyan, Arul M AM

Publication Date: 2021-04-01

Variant appearance in text: ERBB2: S310Y

PubMed Link: 33630025

Variant Present in the following documents:

• jamaoncol-e207987-s004.xlsx, sheet 2

View BVdb publication page

---

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.

Nature Communications

Vandekerkhove, Gillian G; Lavoie, Jean-Michel JM; Annala, Matti M; Murtha, Andrew J AJ; Sundahl, Nora N; Walz, Simon S; Sano, Takeshi T; Taavitsainen, Sinja S; Ritch, Elie E; Fazli, Ladan L; Hurtado-Coll, Antonio A; Wang, Gang G; Nykter, Matti M; Black, Peter C PC; Todenhöfer, Tilman T; Ost, Piet P; Gibb, Ewan A EA; Chi, Kim N KN; Eigl, Bernhard J BJ; Wyatt, Alexander W AW

Publication Date: 2021-01-08

Variant appearance in text: ERBB2: S310Y

PubMed Link: 33420073

Variant Present in the following documents:

• 41467_2020_20493_MOESM3_ESM.xlsx, sheet 8
• 41467_2020_20493_MOESM3_ESM.xlsx, sheet 4
• 41467_2020_20493_MOESM3_ESM.xlsx, sheet 7

View BVdb publication page

---

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications

Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q

Publication Date: 2021-01-04

Variant appearance in text: ERBB2: 929C>A; S310Y

PubMed Link: 33397889

Variant Present in the following documents:

• 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
• 41467_2020_20162_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page

---

The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.

International Journal Of Clinical Oncology

Sunami, Kuniko K; Naito, Yoichi Y; Aimono, Eriko E; Amano, Toraji T; Ennishi, Daisuke D; Kage, Hidenori H; Kanai, Masashi M; Komine, Keigo K; Koyama, Takafumi T; Maeda, Takahiro T; Morita, Sachi S; Sakai, Daisuke D; Kohsaka, Shinji S; Tsuchihara, Katsuya K; Yoshino, Takayuki T

Publication Date: 2021-03

Variant appearance in text: ERBB2: S310Y

PubMed Link: 33385275

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2-targeted therapies.

Clinical And Translational Medicine

Zhang, Cheng C; Chen, Zuhua Z; Chong, Xiaoyi X; Chen, Yang Y; Wang, Zhenghang Z; Yu, Ruoying R; Sun, Tingting T; Chen, Xiaoxi X; Shao, Yang Y; Zhang, Xiaotian X; Gao, Jing J; Shen, Lin L

Publication Date: 2020-12

Variant appearance in text: ERBB2: S310Y

PubMed Link: 33377634

Variant Present in the following documents:

• Main text

View BVdb publication page

---